TP53 loss creates therapeutic vulnerability in colorectal cancer-Reference-Cited by-同舟云学术

TP53 loss creates therapeutic vulnerability in colorectal cancer

Published:2015-04-22 Issue:7549 Volume:520 Page:697-701
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Liu Yunhua,Zhang Xinna,Han Cecil,Wan Guohui,Huang Xingxu,Ivan Cristina,Jiang Dahai,Rodriguez-Aguayo Cristian,Lopez-Berestein Gabriel,Rao Pulivarthi H.,Maru Dipen M.,Pahl Andreas,He Xiaoming,Sood Anil K.,Ellis Lee M.,Anderl Jan,Lu Xiongbin

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

https://www.nature.com/articles/nature14418.pdf

Reference28 articles.

1. Petitjean, A. et al. Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Hum. Mutat. 28, 622–629 (2007)

2. Vazquez, A. et al. The genetics of the p53 pathway, apoptosis and cancer therapy. Nature Rev. Drug Discov. 7, 979–987 (2008)

3. Cheok, C. F. et al. Translating p53 into the clinic. Nature Rev. Clin. Oncol. 8, 25–37 (2011)

4. Lane, D. P., Cheok, C. F. & Lain, S. p53-based cancer therapy. Cold Spring Harb. Perspect. Biol. 2, a001222 (2010)

5. Chène, P. Inhibiting the p53–MDM2 interaction: an important target for cancer therapy. Nature Rev. Cancer 3, 102–109 (2003)

Cited by 193 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in siRNA Drug Delivery Strategies for Targeted TNBC Therapy;Bioengineering;2024-08-14

2. Somatic Mutation Profile as a Predictor of Treatment Response and Survival in Unresectable Pancreatic Ductal Adenocarcinoma Treated with FOLFIRINOX and Gemcitabine Nab-Paclitaxel;Cancers;2024-08-01

3. Peptides for microbe-induced cancers: latest therapeutic strategies and their advanced technologies;Cancer and Metastasis Reviews;2024-07-15

4. Increased transcriptional elongation and RNA stability of GPCR ligand binding genes unveiled via RNA polymerase II degradation;Nucleic Acids Research;2024-06-06

5. Understanding the complexity of p53 in a new era of tumor suppression;Cancer Cell;2024-06